APA (7th ed.) Citation

L, G., P, G., A, F., V, C., B, G., CJ, P., . . . A, Á. (2024). Cystic fibrosis: Desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor. Frontiers in pharmacology, 15, 1392986. https://doi.org/10.3389/fphar.2024.1392986

Chicago Style (17th ed.) Citation

L, Gómez-Ganda, Galván-Blasco P, Fernández-Polo A, Cardona V, García-Palop B, Parramón-Teixidó CJ, Polverino E, and Álvarez-Fernández A. "Cystic Fibrosis: Desensitization in Delayed Hypersensitivity Reactions to Elexacaftor/tezacaftor/ivacaftor." Frontiers in Pharmacology 15 (2024): 1392986. https://doi.org/10.3389/fphar.2024.1392986.

MLA (9th ed.) Citation

L, Gómez-Ganda, et al. "Cystic Fibrosis: Desensitization in Delayed Hypersensitivity Reactions to Elexacaftor/tezacaftor/ivacaftor." Frontiers in Pharmacology, vol. 15, 2024, p. 1392986, https://doi.org/10.3389/fphar.2024.1392986.